Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.

Authors :: Marouf A
Cottereau AS
Kanoun S
Deschamps P
Meignan M
Franchi P
Sibon D
Antoine C
Gastinne T
Borel C
Hammoud M
Sicard G
Gille R
Cavalieri D
Stamatoullas A
Filliatre-Clement L
Lazarovici J
Chauchet A
Fornecker LM
Amorin S
Rocquet M
Raus N
Burroni B
Rubio MT
Bouscary D
Quittet P
Casasnovas RO
Brice P
Ghesquieres H
Tamburini J
Deau B
Source :: Haematologica [Haematologica] 2022 Jul 01; Vol. 107 (7), pp. 1681-1686. Date of Electronic Publication: 2022 Jul 01.
Publication Year :: 2022

Subjects :: Brentuximab Vedotin
Humans
Salvage Therapy
Stem Cell Transplantation
Transplantation, Autologous
Hematopoietic Stem Cell Transplantation
Hodgkin Disease drug therapy
Immunoconjugates therapeutic use

Full Text Access

Tools